- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.07. | FDA rejects Hengrui, Elevar's PD-1 liver cancer combo for a 3rd time | ||
| 10.07. | Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector | ||
| 10.07. | Fierce Pharma Asia-More AstraZeneca China deals; Kailera, Hengrui's oral GLP-1 data; Scrutiny of Chinese trials | ||
| 10.07. | J&J's Tremfya retakes ad spending throne in June as Haleon tops pharma's World Cup airings | ||
| 09.07. | AstraZeneca, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction | ||
| 09.07. | In compensation push, HHS gears up to draft COVID vaccine injury table | ||
| 09.07. | Ipsen's Botox rival Dysport charts new horizons with dual phase 3 wins in migraine | ||
| 09.07. | Novo Nordisk asks public to 'Meet Me in the Middle' in new obesity experience installation | ||
| 09.07. | Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue | ||
| 08.07. | CureDuchenne lights the candles with DMD public service campaign highlighting birthdays | ||
| 08.07. | FDA halts release of new drug rejection letters while working to formalize policy | ||
| 08.07. | Foreign drugmaker caught faking doctors' petition to evade China's price cut scheme | ||
| 08.07. | Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition | ||
| 08.07. | Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts | ||
| 08.07. | Catalent sells UK facility to Codis, expands Nanoscope partnership | ||
| 07.07. | FDA approves Vera's dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka | ||
| 07.07. | Novartis dismisses 322 more staffers based out of US headquarters | ||
| 07.07. | Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial | ||
| 07.07. | On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa | ||
| 07.07. | Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B | ||
| 07.07. | Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub | ||
| 07.07. | Skin quality driving widespread quality-of-life issues: survey | ||
| 06.07. | FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2 | ||
| 06.07. | Amgen issues recall for close to 1M heart med bottles due to contamination | ||
| 01.07. | Lonza expands partnership with US drugmaker, boosts capacity for ADCs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.